HK added that these moves, paired with domestic manufacturing boosts and export support, let clinics roll out high-tech lasers and diagnostics without the hefty price tag. “These duty cuts, coupled with support for domestic manufacturing and exports, enable clinics to deploy cutting-edge lasers and diagnostics affordably, while streamlined regulations accelerate approvals for innovations like Aerolase’s high-power aesthetic systems. Incentives for technology adoption and clinical training empower seamless integration, enhancing precision in dermatology, pain management, and chronic care, as infrastructure scales nationwide. Overall, these measures drive efficient, accessible care, fuel a robust med-tech industry, and position India as a global health innovation hub.”
